
Scan beyond Herbalife and compare how other discounted companies are positioning for their own turnarounds with the hand picked 30 high quality undervalued stocks.
To own Herbalife, you need to believe the wellness platform shift can turn early product and tech bets into steadier customer demand and better use of its large distributor base. The key near term catalyst is execution, especially in regions that are only just stabilizing. The new buyback does not change that operational hurdle.
The biggest risk is that flat or falling volumes in mature markets, plus regulatory pressure on multi level marketing and supplement claims, keep sales and margins under strain. If earnings stay patchy, the share repurchase program may have limited effect on the overall business trajectory.
The fresh US$250 million share repurchase authorization is the headline move tied to this update. It connects directly to the wellness transition because it absorbs cash that might otherwise sit idle while management works through a slow, region by region reset in volumes and profitability.
For you, the interesting angle is timing and discipline. Buybacks over three years rely on Herbalife continuing to generate enough cash while managing debt, interest coverage and regulatory costs. Execution on the wellness platform, digital tools, and product pipeline remains the real swing factor that determines how impactful those future repurchases feel.
Herbalife's current analyst narrative points to forecast revenues of US$5.6b and earnings of US$506.4 million by 2029. This outlook is based on an expected 2.6% yearly revenue growth rate and a move from current earnings of US$164.2 million to that 2029 consensus, which represents roughly a 3x increase in profits from current levels.
Uncover how Herbalife's fair value indicates a 39% potential upside to its current price before sentiment closes that discount gap.
For Herbalife, the sharpest contrast comes from the bearish focus on high debt. Those analysts see tighter room to move and were pencilling in 2029 earnings of US$296.7 million on revenue of about US$5.5b before this buyback news. That is far more cautious than consensus, so treat it as one of several viewpoints to explore.
Explore 4 other Herbalife fair value estimates, including one that suggests it could be worth just $17.00!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If the Herbalife story has you thinking about where else discounted or resilient businesses might sit on your watchlist, the Simply Wall St Screener can help you cast the net wider without getting lost in noise.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com